<?xml version="1.0" encoding="UTF-8"?>
<p id="p0050">A recent research reported that SARS-Cov-2-infected patients with diabetes were at a higher risk of developing severe pneumonia with uncontrolled inflammatory responses and hypercoagulable state associated with dysregulation of glucose metabolism compared with Covid-19 individuals without DM (
 <xref rid="bib31" ref-type="bibr">Guo et al., 2020</xref>). Furthermore, serum levels of inflammatory mediators, including IL-6 and C-reactive protein, were remarkably increased compared to those in nondiabetic patients, suggesting that diabetic patients are more vulnerable to the high inflammatory wave leading to rapid deterioration (
 <xref rid="bib31" ref-type="bibr">Guo et al., 2020</xref>). Individuals with diabetes mellitus and severe obesity (BMI ≥40 kg/m
 <sup>2</sup>) are more likely to be infected and are at a higher risk for complications and death from Covid-19 (
 <xref rid="bib52" ref-type="bibr">Muniyappa and Gubbi, 2020</xref>).
</p>
